Structure Database (LMSD)
| LM_ID | Common Name | Systematic Name | Main Class | Sub Class | Mass | Formula |
|---|---|---|---|---|---|---|
| LMFA03010220 | 15S-hydroperoxy-PGD2 | 9S-hydroxy-11-oxo-15S-hydroperoxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 368.22 | C20H32O6 |
| LMFA03010217 | 15S-hydroperoxy-PGE2 | 9-oxo-11R-hydroxy-15S-hydroperoxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 368.22 | C20H32O6 |
| LMFA03010024 | 19R-hydroxy-PGE2 | 9-oxo-11R,15S,19R-trihydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 368.22 | C20H32O6 |
| LMFA03010216 | 20-hydroxy-PGD2 | 9S,15S,20-trihydroxy-11-oxo-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 368.22 | C20H32O6 |
| LMFA03010014 | 20-hydroxy-PGE2 | 9-oxo-11R,15S,20-trihydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 368.22 | C20H32O6 |
| LMFA03010012 | 6-keto PGE1 | 6,9-dioxo-11R,15S-dihydroxy-13E-prostenoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 368.22 | C20H32O6 |
| LMFA03010149 | D17, 6-keto PGF1a | 6-oxo-9S,11R,15S-trihydroxy-13E,17Z-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 368.22 | C20H32O6 |
| LMFA03010009 | PGG2 | 9S,11R-epidioxy-15S-hydroperoxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 368.22 | C20H32O6 |
| LMFA03020059 | 20-COOH-10,11-dihydro-LTB4 | (5R,6Z,8E,12R,14Z)-5,12-dihydroxyicosa-6,8,14-trienedioic acid | Eicosanoids [FA03] | Leukotrienes [FA0302] | 368.22 | C20H32O6 |
| LMFA03020061 | 20-dihydroxyleukotriene B4 | (5R,6Z,8E,10E,12S,14Z)-5,12,20,20-tetrahydroxyicosa-6,8,10,14-tetraenoic acid | Eicosanoids [FA03] | Leukotrienes [FA0302] | 368.22 | C20H32O6 |
| LMFA03020068 | 5(6)-Epoxy Prostaglandin E1 | 4-(3-{[(1S,2S,3S)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]methyl}oxiran-2-yl)butanoic acid | Eicosanoids [FA03] | Leukotrienes [FA0302] | 368.22 | C20H32O6 |
| LMFA03030014 | 11-Dehydro-thromboxane B2 | (5E)-7-[(2R,3S,4S)-4-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-6-oxooxan-3-yl]hept-5-enoic acid | Eicosanoids [FA03] | Thromboxanes [FA0303] | 368.22 | C20H32O6 |
| LMFA03030004 | 11-dehydro-TXB2 | 9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E-dien-1-oic acid | Eicosanoids [FA03] | Thromboxanes [FA0303] | 368.22 | C20H32O6 |
| LMFA03030016 | Thromboxane B3 | (5E)-7-{4,6-dihydroxy-2-[(1E,5E)-3-hydroxyocta-1,5-dien-1-yl]oxan-3-yl}hept-5-enoic acid | Eicosanoids [FA03] | Thromboxanes [FA0303] | 368.22 | C20H32O6 |
| LMFA03030006 | TXB3 | 9S,11,15S-trihydroxy-thromboxa-5Z,13E,17Z-trien-1-oic acid | Eicosanoids [FA03] | Thromboxanes [FA0303] | 368.22 | C20H32O6 |
| LMFA03060046 | 5,12-diHPETE | 5,12-dihydroperoxy-6,8,10,14-eicosatetraenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306] | 368.22 | C20H32O6 |
| LMFA03060047 | 5,15-diHPETE | 5,15-dihydroperoxy-6,8,11,13-eicosatetraenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306] | 368.22 | C20H32O6 |
| LMFA03060097 | 5S,15S-diHPETE | 5S,15S-dihydroperoxy-6E,8Z,11Z,13E-eicosatetraenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306] | 368.22 | C20H32O6 |
| LMFA03060048 | 8,15-diHPETE | 8,15-dihydroperoxy-5,9,11,13-eicosatetraenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306] | 368.22 | C20H32O6 |
| LMFA03060098 | 8S,15S-diHPETE | 8S,15S-dihydroperoxy-5Z,9E,11Z,13E-eicosatetraenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosatetraenoic acids [FA0306] | 368.22 | C20H32O6 |
Download LMSD record summary for FA 20:4;O4